Evaluation of a Rapid Immunoassay for Molecular Subphenotype Classification in Pediatric Acute Cardiorespiratory Failure
Authors:
Preprint
- 23 September 2025
- preprint
- Published by Springer Nature in Research Square
Abstract
Molecular subphenotypes, identified through biomarker profiling independent of clinical diagnosis, have the potential to guide targeted therapeutics in critical care. We have previously published that intensive insulin management has subphenotype-specific beneficial effects among children with hyperglycemia accompanying cardiorespiratory failure. However, due to the operational aspects of biomarker assays, prospective real-time application of subphenotype-based strategies remains daunting. This study compared biomarker values measured via a rapid immunoassay requiring minimal handling to a conventional laboratory-based multiplex assay, assessed its ability to classify subphenotypes with a parsimonious classifier, and compared clinical outcomes between rapid immunoassay-based subphenotypes. This retrospective multicenter study included re-assaying plasma samples from 269 children with acute cardiorespiratory failure and hyperglycemia. Latent class analysis (LCA) was previously used to derive hyper-inflammatory and hypo-inflammatory classes. A parsimonious classifier was fit to LCA-derived subphenotypes and produced a model consisting of IL-6, IL-8, and sTNFR-1. We found that, despite the rapid immunoassay systematically overestimating biomarker values relative to the conventional assay, biomarkers were strongly correlated between platforms (Pearson r = 0.87–0.93). Using the parsimonious classifier, subphenotype classifications matched between platforms in 95% of patients (n = 256/269). When compared to previously derived LCA-derived subphenotypes, rapid immunoassay-based subphenotypes demonstrated an AUC of 0.90 (95% CI 0.85–0.95). The rapid immunoassay-based hyper-inflammatory class was associated with higher mortality (26% vs. 11%; P = 0.01) and heterogeneity of treatment effect to intensive insulin management (interaction P = 0.01). Our findings suggest that subphenotyping using a rapid immunoassay is feasible and accurate, laying the foundation for future precision medicine strategies in pediatric critical care.Keywords
All Related Versions
This publication has 20 references indexed in Scilit:
- Identification of molecular subphenotypes in two cohorts of paediatric ARDSThorax, 2023
- Integrated Analysis of Blood and Urine Biomarkers to Identify Acute Kidney Injury Subphenotypes and Associations With Long-term OutcomesAmerican Journal of Kidney Diseases, 2023
- Advancing precision medicine for acute respiratory distress syndromeThe Lancet Respiratory Medicine, 2022
- Subphenotypes in critical care: translation into clinical practiceThe Lancet Respiratory Medicine, 2020
- Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trialsThe Lancet Respiratory Medicine, 2020
- Quantitative analysis of four protein biomarkers: An automated microfluidic cartridge-based method and its comparison to colorimetric ELISAJournal of Immunological Methods, 2017
- Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trialsThe Lancet Respiratory Medicine, 2014
- Multinomial Least Angle RegressionIEEE Transactions on Neural Networks and Learning Systems, 2011
- Optimal Cut-point and Its Corresponding Youden Index to Discriminate Individuals Using Pooled Blood SamplesEpidemiology, 2005
- Evaluation of regression procedures for methods comparison studiesClinical Chemistry, 1993